Skip to main content
. 2016 Aug 12;16:634. doi: 10.1186/s12885-016-2657-7

Fig. 1.

Fig. 1

a FDG-PET/CT in December 2012, prior to BRAF inhibitor therapy, showed intensely FDG avid lesions in the orbit, the parotid glad and the lung post AdCD40L treatment. b PET/CT in May 2013, after the initiation of the treatment with vemurafenib, showed that all the previously described intensely FDG avid lesions had lower SUVmax uptake. Physiologic FDG uptake in right posterior vocal cord is observed. Black arrow: metastasis in right parotid gland. White arrow: metastasis in right orbit. Striped arrow: lung metastasis